Levodopa and Carbidopa Controlled Release Matrix Tablets: Formulation and InVitro Evaluation - Couverture souple

Somagoni, Jagan Mohan; Madhusudan Rao, Y.; Kishan, V.

 
9783838348117: Levodopa and Carbidopa Controlled Release Matrix Tablets: Formulation and InVitro Evaluation
Couverture souple
ISBN 10 : 3838348117 ISBN 13 : 9783838348117
Editeur : LAP Lambert Academic Publishing, 2010

Synopsis

In recent years, in association with progress and innovation in the field of pharmaceutical technology, there has been an increasing effort to develop prolonged release dosage forms for many drugs. Correspondingly, a growing number of new prolonged release dosage forms have been submitted for regulatory approval. Prolonged release dosage forms have many advantages in safety and efficacy over immediate release drug products in that the frequency of dosing can be reduced, drug efficacy can be prolonged and the incidence and/or intensity of adverse effects can be decreased. However, some prolonged release dosage forms have less clear rationale or are developed for active ingredients which are not appropriate for prolonged release dosage forms. In other cases, prolonged release dosage forms are designed without full consideration of the basic properties of the drugs. Moreover, standards for dissolution tests, which are important for evaluating prolonged release dosage forms, have not appropriately been established. As a result, it is often difficult to evaluate whether a prolonged release dosage form is acceptable or not.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP Lambert Academic Publishing
Date d'édition
2010
Langue
anglais
ISBN 10 
3838348117
ISBN 13 
9783838348117
Reliure
Broché
Nombre de pages
72
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne